MediPoint: Magnetic Resonance Imaging Systems - EU Analysis
and Market Forecasts
Summary
The global magnetic resonance imaging (MRI) market is a shifting, capital equipment market that is saturated with numerous players developing innovative technologies. Given their impressive safety and efficacy as well as non-invasive nature, MRI systems have seen continued adoption since they were first introduced to the healthcare market. Rapid advances in the field imaging along with the development of MRI safe technologies have greatly expanded the potential of therapeutic applications.
In France there is no market for low-field MRI system sales, although the market for mid- and high-field systems is expected to undergo significant growth in the coming years. MRI is one of the fastest growing device market segments in the country, and will be valued at over $181m by 2020. Valued at just $30.8m in 2013, the high-field MRI market in the UK is one of the smallest in Europe, due to poor reimbursement and slow adoption of advanced systems.
Scope
- An overview of Magnetic Resonance Imaging Systems, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized the EU Magnetic Resonance Imaging Systems market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
- Investigation of current and future market competition for Magnetic Resonance Imaging Systems.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the Magnetic Resonance Imaging Systems sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors
Reasons to buy
- Understand the trends shaping and driving the EU Magnetic Resonance Imaging Systems market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the EU Magnetic Resonance Imaging Systems market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the markets device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- Whats the next big thing in the EU Magnetic Resonance Imaging Systems market landscape? Identify, understand and capitalize.
Summary
The global magnetic resonance imaging (MRI) market is a shifting, capital equipment market that is saturated with numerous players developing innovative technologies. Given their impressive safety and efficacy as well as non-invasive nature, MRI systems have seen continued adoption since they were first introduced to the healthcare market. Rapid advances in the field imaging along with the development of MRI safe technologies have greatly expanded the potential of therapeutic applications.
In France there is no market for low-field MRI system sales, although the market for mid- and high-field systems is expected to undergo significant growth in the coming years. MRI is one of the fastest growing device market segments in the country, and will be valued at over $181m by 2020. Valued at just $30.8m in 2013, the high-field MRI market in the UK is one of the smallest in Europe, due to poor reimbursement and slow adoption of advanced systems.
Scope
- An overview of Magnetic Resonance Imaging Systems, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized the EU Magnetic Resonance Imaging Systems market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
- Investigation of current and future market competition for Magnetic Resonance Imaging Systems.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the Magnetic Resonance Imaging Systems sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors
Reasons to buy
- Understand the trends shaping and driving the EU Magnetic Resonance Imaging Systems market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the EU Magnetic Resonance Imaging Systems market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the markets device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- Whats the next big thing in the EU Magnetic Resonance Imaging Systems market landscape? Identify, understand and capitalize.
1.1 List of Tables 14
1.2 List of Figures 19
2 Introduction 21
2.1 Catalyst 22
2.2 Related Reports 22
3 Industry Overview 23
3.1 Overview of MRI Technology 23
3.2 System Overview 24
3.2.1 Pre-Polarizing MRI Systems 25
3.2.2 Diffusion MRI 26
3.2.3 Apparent Diffusion Coefficient 26
3.3 Applications of Technology 27
3.4 Clinical Indications for MRI scans 27
3.5 Procedure Trends 29
3.5.1 Product Lifecycle 29
3.6 Advantages and Disadvantages of Technology 31
3.6.1 Overview 31
3.6.2 MRI Technology SWOT Analysis 31
3.6.3 Claustrophobia Issues with MRI Systems 32
3.6.4 Magnetic Resonance Imaging vs. Computed Tomography 33
3.7 Market Access 34
3.7.1 Product Life Cycle 34
3.7.2 Purchasing Decisions 35
3.7.3 Role of Group Purchasing Organizations 36
3.8 Regulatory Process 38
3.8.1 EU 38
3.9 Current MRI Reimbursement Trends 38
3.9.1 EU 38
3.9.2 France 39
3.9.3 Germany 41
3.9.4 Italy 41
3.9.5 Spain 43
3.9.6 UK 43
3.10 Procedure Trends 44
3.10.1 Neurology 44
3.10.2 Extremity MRI 45
3.10.3 PET/MRI 46
3.10.4 5EU 46
3.10.5 Magnetic Resonance Angiography 47
3.10.6 Magnetic Resonance Spectroscopy 47
3.10.7 Hours of Operation 47
3.10.8 Regulatory Issues/Recalls 47
3.11 Economic Impact 48
3.11.1 Direct Costs 48
3.11.2 Pricing of MRI Systems 49
4 Unmet Needs 55
4.1 Overview 55
4.2 Storing and Managing Patient Data 56
4.3 Multiparametric MRI 57
4.4 Quieter Systems for Improved Patient Comfort 58
4.5 Improved Software to Support Advanced Image Acquisition Hardware 58
4.6 Faster Throughput 61
4.7 Improvements in Patient Comfort 62
5 Market Opportunity Analysis 63
5.1 Overview 63
5.2 Standardization of Scans 64
5.3 Increased Adoption of MRI Throughout the Hospital 65
5.4 Cardiac MRI on the Rise 65
5.5 High-Field MRI in Developing Brains 67
5.6 Permanent Magnets Still Desirable Where Power Unreliable 68
5.7 Imaging Brain Tumors 69
5.8 Cryogen-Free Cooling Systems 69
5.9 Additional Scanners for Outpatient Exams 70
5.10 Breast and Prostate Cancer MRI 71
5.11 Whole-Body MRI for Cancer 72
5.12 Cloud Computing on the Rise 72
5.13 New MRI Technique to Speed Up Diagnosis for Traumatic Brain Injury 73
6 Market Drivers and Barriers 74
6.1 Overview 74
6.2 Driver: Improved Imaging Capabilities of Higher Field Strength 74
6.3 Driver: Low-Quality Images from Older Machines 76
6.4 Driver: High Average Age of MRI Systems 76
6.5 Driver: Difficulty of Achieving Homogenous Signals with Older Systems 77
6.6 Barrier: Fewer Resources for Training on Machines 77
6.7 Barrier: Economic Pressure Reduces New Systems Volume 78
6.8 Barrier: Misuse of Systems 79
6.9 Barrier: Overuse of MRI Systems 80
6.10 Barrier: ISOs a Cheaper Alternative to Service or New Sales from OEM 81
6.11 Barrier: Supeconducting MRI Magnet Producers 82
6.12 Barrier: Uneven Reimbursement for MRI Procedures 83
7 Competitive Assessment 84
7.1 Full Profiles for Key Products 84
7.1.1 Oasis (Hitachi) 84
7.1.2 Echelon Oval (Hitachi) 85
7.1.3 Discovery MR750w (GE Healthcare) 86
7.1.4 Optima MR360 Advance (GE Healthcare) 87
7.1.5 Optima MR450w (GE Healthcare) 88
7.1.6 Signa HDxt (GE Healthcare) 89
7.1.7 Vantage Titen (Philips Healthcare) 90
7.1.8 Ingenia (Philips Healthcare) 91
7.1.9 Achieva TX (Philips Healthcare) 92
7.1.10 Magnetom Aera (Siemens Healthcare) 93
7.1.11 Magnetom C! (Siemens Healthcare) 94
7.1.12 Magnetom Spectra (Siemens Healthcare) 95
7.1.13 NSM-S15 (Neusoft Medical Systems) 96
7.2 Classification Based on Field Strength 97
7.2.1 Low-Field MRI Systems 97
7.2.2 Mid-Field MRI Systems 99
7.2.3 High-Field MRI Systems 101
8 Pipeline Assessment 103
8.1 11.7T MRI System (Neurospin) 103
8.1.1 Overview 103
8.1.2 SWOT 103
8.2 Aurora PET/MRI System (Aurora Imaging Technology) 103
8.2.1 Overview 103
8.2.2 SWOT 104
8.3 Neona (Time Medical) 104
8.3.1 Overview 104
8.3.2 SWOT 104
8.4 GE 7.0T MRI Scanner (GE Healthcare) 105
8.4.1 Overview 105
8.4.2 SWOT 105
8.5 Signa PET/MRI (GE Healthcare) 105
8.5.1 Overview 105
8.5.2 SWOT 106
9 Current and Future Players 107
9.1 Overview 107
9.2 Aurora Imaging 107
9.2.1 Overview 107
9.2.2 Portfolio Assessment 108
9.2.3 SWOT Analysis 108
9.3 China Resources Wandong Medical Equipment 109
9.3.1 Overview 109
9.3.2 Portfolio Assessment 109
9.3.3 SWOT Analysis 110
9.4 Esaote S.p.A. 110
9.4.1 Overview 110
9.4.2 Portfolio Assessment 111
9.4.3 SWOT Analysis 111
9.5 Fonar Corporation 111
9.5.1 Overview 111
9.5.2 Portfolio Assessment 112
9.5.3 SWOT Analysis 112
9.6 GE Healthcare 113
9.6.1 Overview 113
9.6.2 Portfolio Assessment 113
9.6.3 SWOT Analysis 115
9.7 Hitachi Medical Corporation 115
9.7.1 Overview 115
9.7.2 Portfolio Assessment 116
9.7.3 SWOT Analysis 117
9.8 Hologic 117
9.8.1 Overview 117
9.8.2 Portfolio Assessment 118
9.8.3 SWOT Analysis 118
9.9 Mindray 119
9.9.1 Overview 119
9.9.2 Portfolio Assessment 119
9.9.3 SWOT Analysis 120
9.10 Neusoft Medical 120
9.10.1 Overview 120
9.10.2 Portfolio Assessment 121
9.10.3 SWOT Analysis 121
9.11 Ningbo Xingaoyi Medical 121
9.11.1 Overview 121
9.11.2 Portfolio Assessment 122
9.11.3 SWOT Analysis 122
9.12 Philips Healthcare 123
9.12.1 Overview 123
9.12.2 Portfolio Assessment 123
9.12.3 SWOT Analysis 125
9.13 Siemens Healthcare 125
9.13.1 Overview 125
9.13.2 Portfolio Assessment 126
9.13.3 SWOT Analysis 128
9.14 Sina Healthcare 128
9.14.1 Overview 128
9.14.2 Portfolio Assessment 129
9.14.3 SWOT Analysis 130
9.15 Time Medical 130
9.15.1 Overview 130
9.15.2 Portfolio Assessment 131
9.15.3 SWOT Analysis 132
9.16 Toshiba Medical Systems Corporation 132
9.16.1 Overview 132
9.16.2 Portfolio Assessment 133
9.16.3 SWOT Analysis 133
10 Stategic Competitive Assessment 134
10.1 Company Market Share 134
10.1.1 5EU 134
10.1.2 France 135
10.1.3 Germany 136
10.1.4 Italy 137
10.1.5 Spain 138
10.1.6 UK 139
11 Market Outlooks by Market Segment 141
11.1 Market Segment by Country 141
11.1.1 France 141
11.1.2 Germany 143
11.1.3 Italy 144
11.1.4 Spain 145
11.1.5 UK 146
12 Market Outlooks by Geography 147
12.1 5EU 147
12.1.1 5EU Market Share by Country 147
12.1.2 5EU Market Value by Market Segment 149
12.2 France 150
12.2.1 Market Value by Market Segment 150
12.2.2 Installed Base of MRI Systems 151
12.3 Germany 152
12.3.1 Market Value by Market Segment 152
12.3.2 Installed Base of MRI Systems 153
12.4 Italy 154
12.4.1 Market Value by Market Segment 154
12.4.2 Installed Base of MRI Systems 155
12.5 Spain 156
12.5.1 Market Value by Market Segment 156
12.5.2 Installed Base of MRI Systems 157
12.6 United Kingdom 158
12.6.1 Market Value by Market Segment 158
12.6.2 Installed Base of MRI Systems 159
13 Appendix 161
13.1 Bibliography 161
13.2 Abbreviations 167
13.3 Report Methodology 170
13.3.1 Overview 170
13.3.2 Coverage 170
13.3.3 Secondary Research 170
13.4 Forecasting Methodology 171
13.5 Primary Research Key Opinion Leaders 172
13.6 Primary Research Physician and Industry Overviews 172
13.6.1 Expert Panel Validation 175
13.7 Physicians & Experts Included in this Study 175
13.8 About the Authors 177
13.8.1 Analysts 177
13.8.2 Global Head of Healthcare 177
13.9 About MediPoint 178
13.10 About GlobalData 178
13.11 Disclaimer 178
List Of Tables
Table 1: MRI Procedure Targets 28
Table 2: Indications for an Immediate Emergency MRI 29
Table 3: Advantages and Disadvantages of MRI 31
Table 4: Magnetic Resonance Imaging Technology SWOT Analysis 32
Table 5: Selected Group Purchasing Organizations in the US and EU 37
Table 6: France Average Selling Price by Market Segment (2011-2020), $m 49
Table 7: Germany Average Selling Price by Market Segment (2011-2020), $m 50
Table 8: Italy Average Selling Price by Market Segment (2011-2020), $m 51
Table 9: Spain Average Selling Price by Market Segment (2011-2020), $m 52
Table 10: United Kingdom Average Selling Price by Market Segment (2011-2020), $m 53
Table 11: MRI Applications and Future Market Potential 64
Table 12: SWOT Analysis Oasis 85
Table 13: SWOT Analysis Echelon Oval 86
Table 14: SWOT Analysis Discovery MR750w 87
Table 15: SWOT Analysis Optima MR360 Advance 88
Table 16: SWOT Analysis Optima MR450w 89
Table 17: SWOT Analysis Signa HDxt 90
Table 18: SWOT Analysis Vantage Titen 91
Table 19: SWOT Analysis Ingenia 92
Table 20: SWOT Analysis Achieva TX 93
Table 21: SWOT Analysis Magnetom Aera 94
Table 22: SWOT Analysis Magnetom C! 95
Table 23: SWOT Analysis Magnetom Spectra 96
Table 24: SWOT Analysis NSM-S15 96
Table 25: SWOT Analysis Low-Field MRI Systems 97
Table 26: Low-Field MRI Systems 98
Table 27: SWOT Analysis Mid-Field MRI Systems 99
Table 28: Mid-Field MRI Systems 100
Table 29: SWOT Analysis High-Field MRI Systems 101
Table 30: High-Field MRI Systems 102
Table 31: SWOT Analysis 11.7T MRI (Neurospin) 103
Table 32: SWOT Analysis Aurora PET/MRI System (Aurora Imaging Technology) 104
Table 33: SWOT Analysis Neona (Time Medical) 104
Table 34: SWOT Analysis 7.0T MRI Scanner (GE Healthcare) 105
Table 35: SWOT Analysis Signa PET/MR (GE Healthcare) 106
Table 36: Company Profile Aurora Imaging 108
Table 37: Aurora Imaging, MRI System Device Portfolio 108
Table 38: SWOT Analysis Aurora Imaging 108
Table 39: Company Profile China Resources Wandong Medical Equipment 109
Table 40: China Resources Wandong Medical Equipment, MRI System Device Portfolio 109
Table 41: SWOT Analysis China Resources Wandong Medical Equipment 110
Table 42: Company Profile Esaote S.p.A. 110
Table 43: Esaote S.p.A., MRI System Device Portfolio 111
Table 44: SWOT Analysis Esaote S.p.A. 111
Table 45: Company Profile Fonar Corporation 112
Table 46: Fonar Corporation, MRI System Device Portfolio 112
Table 47: SWOT Analysis Fonar Corporation 112
Table 48: Company Profile GE Healthcare 113
Table 49: GE Healthcare, MRI System Device Portfolio 114
Table 50: SWOT Analysis GE Healthcare 115
Table 51: Company Profile Hitachi Medical Corporation 116
Table 52: Hitachi Medical Corporation, MRI System Device Portfolio 116
Table 53: SWOT Analysis Hitachi Medical 117
Table 54: Company Profile Hologic 118
Table 55: SWOT Analysis Hologic 118
Table 56: Company Profile Mindray 119
Table 57: Mindray, MRI System Device Portfolio 119
Table 58: SWOT Analysis Mindray 120
Table 59: Company Profile Neusoft Medical 120
Table 60: Neusoft Medical, MRI System Device Portfolio 121
Table 61: SWOT Analysis Neusoft Medical 121
Table 62: Company Profile Ningbo Xingaoyi Medical 122
Table 63: Ningbo Xingaoyi Magnetism, MRI System Device Portfolio 122
Table 64: SWOT Analysis Ningbo Xingaoyi Magnetism 122
Table 65: Company Profile Philips Healthcare 123
Table 66: Philips Healthcare, MRI System Device Portfolio 124
Table 67: SWOT Analysis Philips Healthcare 125
Table 68: Company Profile Siemens Healthcare 126
Table 69: Siemens Healthcare, MRI System Device Portfolio 127
Table 70: SWOT Analysis Siemens Healthcare 128
Table 71: Company Profile Sina Healthcare 129
Table 72: Sina Healthcare, MRI System Device Portfolio 130
Table 73: SWOT Analysis Sina Healthcare 130
Table 74: Company Profile Time Medical 131
Table 75: Time Medical, MRI System Device Portfolio 131
Table 76: SWOT Analysis Time Medical 132
Table 77: Company Profile Toshiba 132
Table 78: Toshiba, MRI System Device Portfolio 133
Table 79: SWOT Analysis Toshiba 133
Table 80: 5EU Market Sales for MRI Systems (2012) 134
Table 81: France Market Sales for MRI Systems (2012) 135
Table 82: Germany Market Sales for MRI Systems (2012) 136
Table 83: Italy Market Sales for MRI Systems (2012) 137
Table 84: Spain Market Sales for MRI Systems (2012) 138
Table 85: United Kingdom Market Sales for MRI Systems (2012) 139
Table 86: France Market Segment, 2012 & 2020 141
Table 87: Germany Market Segment, 2012 & 2020 143
Table 88: Italy Market Segment, 2012 & 2020 144
Table 89: Spain Market Segment, 2012 & 2020 145
Table 90: United Kingdom Market Segment, 2012 & 2020 146
Table 91: 5EU Market by Country, 2012 & 2020 147
Table 92: 5EU Market Value by Market Segment for MRI Systems (2011-2020), $m 149
Table 93: France Market Value Forecast by Market Segment (2011-2020), $m 150
Table 94: France Installed Base of MRI Systems (2011-2020) 151
Table 95: Germany Market Value Forecast by Market Segment (2011-2020), $m 152
Table 96: Germany Installed Base of MRI Systems (2011-2020) 153
Table 97: Italy Market Value Forecast by Market Segment (2011-2020), $m 154
Table 98: Italy Installed Base of MRI Systems (2011-2020) 155
Table 99: Spain Market Value Forecast by Market Segment (2011-2020), $m 156
Table 100: Spain Installed Base of MRI Systems (2011-2020) 157
Table 101: United Kingdom Market Value Forecast by Market Segment (2011-2020), $m 158
Table 102: United Kingdom Installed Base of MRI Systems (2011-2020) 159
Table 103: Primary Research Interviews Completed by Country 173
Table 104: Primary Research Interviews Completed by Designation 174
List Of Figures
Figure 1: France Average Selling Price by Market Segment 50
Figure 2: Germany Average Selling Price by Market Segment 51
Figure 3: Italy Average Selling Price by Market Segment 52
Figure 4: Spain Average Selling Price by Market Segment 53
Figure 5: United Kingdom Average Selling Price by Market Segment 54
Figure 6: Average Age for Magnetic Resonance Imaging Machines in 5EU in 2013 77
Figure 7: 5EU Market Share for MRI Systems (2012) 135
Figure 8: France Market Share for MRI Systems (2012) 136
Figure 9: Germany Market Share for MRI Systems (2012) 137
Figure 10: Italy Market Share for MRI Systems (2012) 138
Figure 11: Spain Market Share for MRI Systems (2012) 139
Figure 12: United Kingdom Market Share for MRI Systems (2012) 140
Figure 13: France Market Segment, 2012 & 2020 142
Figure 14: Germany Market Segment, 2012 & 2020 143
Figure 15: Italy Market Segment, 2012 & 2020 144
Figure 16: Spain Market Segment, 2012 & 2020 145
Figure 17: United Kingdom Market Segment, 2012 & 2020 146
Figure 18: 5EU Market by Country, 2012 & 2020 148
Figure 19: 5EU Market Value by Market Segment for MRI Systems (2011-2020), $m 149
Figure 20: France Market Value Forecast by Market Segment (2011-2020), $m 151
Figure 21: France Installed Base of MRI Systems (2011-2020) 152
Figure 22: Germany Market Value Forecast by Market Segment (2011-2020), $m 153
Figure 23: Germany Installed Base of MRI Systems (2011-2020) 154
Figure 24: Italy Market Value Forecast by Market Segment (2011-2020), $m 155
Figure 25: Italy Installed Base of MRI Systems (2011-2020) 156
Figure 26: Spain Market Value Forecast by Market Segment (2011-2020), $m 157
Figure 27: Spain Installed Base of MRI Systems (2011-2020) 158
Figure 28: United Kingdom Market Value Forecast by Market Segment (2011-2020), $m 159
Figure 29: United Kingdom Installed Base of MRI Systems (2011-2020) 160
Figure 30: Primary Research Interviews Completed by Country 173
Figure 31: Primary Research Interviews Completed by Designation 174
Browse Full Report @
http://www.aarkstore.com/medical-devices/89616/medipoint-magnetic-resonance-imaging-systems-eu-analysis-and-market-forecasts
Contact Details:
Aarkstore Enterprise
Phone: +91 998 729 5242
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
1.2 List of Figures 19
2 Introduction 21
2.1 Catalyst 22
2.2 Related Reports 22
3 Industry Overview 23
3.1 Overview of MRI Technology 23
3.2 System Overview 24
3.2.1 Pre-Polarizing MRI Systems 25
3.2.2 Diffusion MRI 26
3.2.3 Apparent Diffusion Coefficient 26
3.3 Applications of Technology 27
3.4 Clinical Indications for MRI scans 27
3.5 Procedure Trends 29
3.5.1 Product Lifecycle 29
3.6 Advantages and Disadvantages of Technology 31
3.6.1 Overview 31
3.6.2 MRI Technology SWOT Analysis 31
3.6.3 Claustrophobia Issues with MRI Systems 32
3.6.4 Magnetic Resonance Imaging vs. Computed Tomography 33
3.7 Market Access 34
3.7.1 Product Life Cycle 34
3.7.2 Purchasing Decisions 35
3.7.3 Role of Group Purchasing Organizations 36
3.8 Regulatory Process 38
3.8.1 EU 38
3.9 Current MRI Reimbursement Trends 38
3.9.1 EU 38
3.9.2 France 39
3.9.3 Germany 41
3.9.4 Italy 41
3.9.5 Spain 43
3.9.6 UK 43
3.10 Procedure Trends 44
3.10.1 Neurology 44
3.10.2 Extremity MRI 45
3.10.3 PET/MRI 46
3.10.4 5EU 46
3.10.5 Magnetic Resonance Angiography 47
3.10.6 Magnetic Resonance Spectroscopy 47
3.10.7 Hours of Operation 47
3.10.8 Regulatory Issues/Recalls 47
3.11 Economic Impact 48
3.11.1 Direct Costs 48
3.11.2 Pricing of MRI Systems 49
4 Unmet Needs 55
4.1 Overview 55
4.2 Storing and Managing Patient Data 56
4.3 Multiparametric MRI 57
4.4 Quieter Systems for Improved Patient Comfort 58
4.5 Improved Software to Support Advanced Image Acquisition Hardware 58
4.6 Faster Throughput 61
4.7 Improvements in Patient Comfort 62
5 Market Opportunity Analysis 63
5.1 Overview 63
5.2 Standardization of Scans 64
5.3 Increased Adoption of MRI Throughout the Hospital 65
5.4 Cardiac MRI on the Rise 65
5.5 High-Field MRI in Developing Brains 67
5.6 Permanent Magnets Still Desirable Where Power Unreliable 68
5.7 Imaging Brain Tumors 69
5.8 Cryogen-Free Cooling Systems 69
5.9 Additional Scanners for Outpatient Exams 70
5.10 Breast and Prostate Cancer MRI 71
5.11 Whole-Body MRI for Cancer 72
5.12 Cloud Computing on the Rise 72
5.13 New MRI Technique to Speed Up Diagnosis for Traumatic Brain Injury 73
6 Market Drivers and Barriers 74
6.1 Overview 74
6.2 Driver: Improved Imaging Capabilities of Higher Field Strength 74
6.3 Driver: Low-Quality Images from Older Machines 76
6.4 Driver: High Average Age of MRI Systems 76
6.5 Driver: Difficulty of Achieving Homogenous Signals with Older Systems 77
6.6 Barrier: Fewer Resources for Training on Machines 77
6.7 Barrier: Economic Pressure Reduces New Systems Volume 78
6.8 Barrier: Misuse of Systems 79
6.9 Barrier: Overuse of MRI Systems 80
6.10 Barrier: ISOs a Cheaper Alternative to Service or New Sales from OEM 81
6.11 Barrier: Supeconducting MRI Magnet Producers 82
6.12 Barrier: Uneven Reimbursement for MRI Procedures 83
7 Competitive Assessment 84
7.1 Full Profiles for Key Products 84
7.1.1 Oasis (Hitachi) 84
7.1.2 Echelon Oval (Hitachi) 85
7.1.3 Discovery MR750w (GE Healthcare) 86
7.1.4 Optima MR360 Advance (GE Healthcare) 87
7.1.5 Optima MR450w (GE Healthcare) 88
7.1.6 Signa HDxt (GE Healthcare) 89
7.1.7 Vantage Titen (Philips Healthcare) 90
7.1.8 Ingenia (Philips Healthcare) 91
7.1.9 Achieva TX (Philips Healthcare) 92
7.1.10 Magnetom Aera (Siemens Healthcare) 93
7.1.11 Magnetom C! (Siemens Healthcare) 94
7.1.12 Magnetom Spectra (Siemens Healthcare) 95
7.1.13 NSM-S15 (Neusoft Medical Systems) 96
7.2 Classification Based on Field Strength 97
7.2.1 Low-Field MRI Systems 97
7.2.2 Mid-Field MRI Systems 99
7.2.3 High-Field MRI Systems 101
8 Pipeline Assessment 103
8.1 11.7T MRI System (Neurospin) 103
8.1.1 Overview 103
8.1.2 SWOT 103
8.2 Aurora PET/MRI System (Aurora Imaging Technology) 103
8.2.1 Overview 103
8.2.2 SWOT 104
8.3 Neona (Time Medical) 104
8.3.1 Overview 104
8.3.2 SWOT 104
8.4 GE 7.0T MRI Scanner (GE Healthcare) 105
8.4.1 Overview 105
8.4.2 SWOT 105
8.5 Signa PET/MRI (GE Healthcare) 105
8.5.1 Overview 105
8.5.2 SWOT 106
9 Current and Future Players 107
9.1 Overview 107
9.2 Aurora Imaging 107
9.2.1 Overview 107
9.2.2 Portfolio Assessment 108
9.2.3 SWOT Analysis 108
9.3 China Resources Wandong Medical Equipment 109
9.3.1 Overview 109
9.3.2 Portfolio Assessment 109
9.3.3 SWOT Analysis 110
9.4 Esaote S.p.A. 110
9.4.1 Overview 110
9.4.2 Portfolio Assessment 111
9.4.3 SWOT Analysis 111
9.5 Fonar Corporation 111
9.5.1 Overview 111
9.5.2 Portfolio Assessment 112
9.5.3 SWOT Analysis 112
9.6 GE Healthcare 113
9.6.1 Overview 113
9.6.2 Portfolio Assessment 113
9.6.3 SWOT Analysis 115
9.7 Hitachi Medical Corporation 115
9.7.1 Overview 115
9.7.2 Portfolio Assessment 116
9.7.3 SWOT Analysis 117
9.8 Hologic 117
9.8.1 Overview 117
9.8.2 Portfolio Assessment 118
9.8.3 SWOT Analysis 118
9.9 Mindray 119
9.9.1 Overview 119
9.9.2 Portfolio Assessment 119
9.9.3 SWOT Analysis 120
9.10 Neusoft Medical 120
9.10.1 Overview 120
9.10.2 Portfolio Assessment 121
9.10.3 SWOT Analysis 121
9.11 Ningbo Xingaoyi Medical 121
9.11.1 Overview 121
9.11.2 Portfolio Assessment 122
9.11.3 SWOT Analysis 122
9.12 Philips Healthcare 123
9.12.1 Overview 123
9.12.2 Portfolio Assessment 123
9.12.3 SWOT Analysis 125
9.13 Siemens Healthcare 125
9.13.1 Overview 125
9.13.2 Portfolio Assessment 126
9.13.3 SWOT Analysis 128
9.14 Sina Healthcare 128
9.14.1 Overview 128
9.14.2 Portfolio Assessment 129
9.14.3 SWOT Analysis 130
9.15 Time Medical 130
9.15.1 Overview 130
9.15.2 Portfolio Assessment 131
9.15.3 SWOT Analysis 132
9.16 Toshiba Medical Systems Corporation 132
9.16.1 Overview 132
9.16.2 Portfolio Assessment 133
9.16.3 SWOT Analysis 133
10 Stategic Competitive Assessment 134
10.1 Company Market Share 134
10.1.1 5EU 134
10.1.2 France 135
10.1.3 Germany 136
10.1.4 Italy 137
10.1.5 Spain 138
10.1.6 UK 139
11 Market Outlooks by Market Segment 141
11.1 Market Segment by Country 141
11.1.1 France 141
11.1.2 Germany 143
11.1.3 Italy 144
11.1.4 Spain 145
11.1.5 UK 146
12 Market Outlooks by Geography 147
12.1 5EU 147
12.1.1 5EU Market Share by Country 147
12.1.2 5EU Market Value by Market Segment 149
12.2 France 150
12.2.1 Market Value by Market Segment 150
12.2.2 Installed Base of MRI Systems 151
12.3 Germany 152
12.3.1 Market Value by Market Segment 152
12.3.2 Installed Base of MRI Systems 153
12.4 Italy 154
12.4.1 Market Value by Market Segment 154
12.4.2 Installed Base of MRI Systems 155
12.5 Spain 156
12.5.1 Market Value by Market Segment 156
12.5.2 Installed Base of MRI Systems 157
12.6 United Kingdom 158
12.6.1 Market Value by Market Segment 158
12.6.2 Installed Base of MRI Systems 159
13 Appendix 161
13.1 Bibliography 161
13.2 Abbreviations 167
13.3 Report Methodology 170
13.3.1 Overview 170
13.3.2 Coverage 170
13.3.3 Secondary Research 170
13.4 Forecasting Methodology 171
13.5 Primary Research Key Opinion Leaders 172
13.6 Primary Research Physician and Industry Overviews 172
13.6.1 Expert Panel Validation 175
13.7 Physicians & Experts Included in this Study 175
13.8 About the Authors 177
13.8.1 Analysts 177
13.8.2 Global Head of Healthcare 177
13.9 About MediPoint 178
13.10 About GlobalData 178
13.11 Disclaimer 178
List Of Tables
Table 1: MRI Procedure Targets 28
Table 2: Indications for an Immediate Emergency MRI 29
Table 3: Advantages and Disadvantages of MRI 31
Table 4: Magnetic Resonance Imaging Technology SWOT Analysis 32
Table 5: Selected Group Purchasing Organizations in the US and EU 37
Table 6: France Average Selling Price by Market Segment (2011-2020), $m 49
Table 7: Germany Average Selling Price by Market Segment (2011-2020), $m 50
Table 8: Italy Average Selling Price by Market Segment (2011-2020), $m 51
Table 9: Spain Average Selling Price by Market Segment (2011-2020), $m 52
Table 10: United Kingdom Average Selling Price by Market Segment (2011-2020), $m 53
Table 11: MRI Applications and Future Market Potential 64
Table 12: SWOT Analysis Oasis 85
Table 13: SWOT Analysis Echelon Oval 86
Table 14: SWOT Analysis Discovery MR750w 87
Table 15: SWOT Analysis Optima MR360 Advance 88
Table 16: SWOT Analysis Optima MR450w 89
Table 17: SWOT Analysis Signa HDxt 90
Table 18: SWOT Analysis Vantage Titen 91
Table 19: SWOT Analysis Ingenia 92
Table 20: SWOT Analysis Achieva TX 93
Table 21: SWOT Analysis Magnetom Aera 94
Table 22: SWOT Analysis Magnetom C! 95
Table 23: SWOT Analysis Magnetom Spectra 96
Table 24: SWOT Analysis NSM-S15 96
Table 25: SWOT Analysis Low-Field MRI Systems 97
Table 26: Low-Field MRI Systems 98
Table 27: SWOT Analysis Mid-Field MRI Systems 99
Table 28: Mid-Field MRI Systems 100
Table 29: SWOT Analysis High-Field MRI Systems 101
Table 30: High-Field MRI Systems 102
Table 31: SWOT Analysis 11.7T MRI (Neurospin) 103
Table 32: SWOT Analysis Aurora PET/MRI System (Aurora Imaging Technology) 104
Table 33: SWOT Analysis Neona (Time Medical) 104
Table 34: SWOT Analysis 7.0T MRI Scanner (GE Healthcare) 105
Table 35: SWOT Analysis Signa PET/MR (GE Healthcare) 106
Table 36: Company Profile Aurora Imaging 108
Table 37: Aurora Imaging, MRI System Device Portfolio 108
Table 38: SWOT Analysis Aurora Imaging 108
Table 39: Company Profile China Resources Wandong Medical Equipment 109
Table 40: China Resources Wandong Medical Equipment, MRI System Device Portfolio 109
Table 41: SWOT Analysis China Resources Wandong Medical Equipment 110
Table 42: Company Profile Esaote S.p.A. 110
Table 43: Esaote S.p.A., MRI System Device Portfolio 111
Table 44: SWOT Analysis Esaote S.p.A. 111
Table 45: Company Profile Fonar Corporation 112
Table 46: Fonar Corporation, MRI System Device Portfolio 112
Table 47: SWOT Analysis Fonar Corporation 112
Table 48: Company Profile GE Healthcare 113
Table 49: GE Healthcare, MRI System Device Portfolio 114
Table 50: SWOT Analysis GE Healthcare 115
Table 51: Company Profile Hitachi Medical Corporation 116
Table 52: Hitachi Medical Corporation, MRI System Device Portfolio 116
Table 53: SWOT Analysis Hitachi Medical 117
Table 54: Company Profile Hologic 118
Table 55: SWOT Analysis Hologic 118
Table 56: Company Profile Mindray 119
Table 57: Mindray, MRI System Device Portfolio 119
Table 58: SWOT Analysis Mindray 120
Table 59: Company Profile Neusoft Medical 120
Table 60: Neusoft Medical, MRI System Device Portfolio 121
Table 61: SWOT Analysis Neusoft Medical 121
Table 62: Company Profile Ningbo Xingaoyi Medical 122
Table 63: Ningbo Xingaoyi Magnetism, MRI System Device Portfolio 122
Table 64: SWOT Analysis Ningbo Xingaoyi Magnetism 122
Table 65: Company Profile Philips Healthcare 123
Table 66: Philips Healthcare, MRI System Device Portfolio 124
Table 67: SWOT Analysis Philips Healthcare 125
Table 68: Company Profile Siemens Healthcare 126
Table 69: Siemens Healthcare, MRI System Device Portfolio 127
Table 70: SWOT Analysis Siemens Healthcare 128
Table 71: Company Profile Sina Healthcare 129
Table 72: Sina Healthcare, MRI System Device Portfolio 130
Table 73: SWOT Analysis Sina Healthcare 130
Table 74: Company Profile Time Medical 131
Table 75: Time Medical, MRI System Device Portfolio 131
Table 76: SWOT Analysis Time Medical 132
Table 77: Company Profile Toshiba 132
Table 78: Toshiba, MRI System Device Portfolio 133
Table 79: SWOT Analysis Toshiba 133
Table 80: 5EU Market Sales for MRI Systems (2012) 134
Table 81: France Market Sales for MRI Systems (2012) 135
Table 82: Germany Market Sales for MRI Systems (2012) 136
Table 83: Italy Market Sales for MRI Systems (2012) 137
Table 84: Spain Market Sales for MRI Systems (2012) 138
Table 85: United Kingdom Market Sales for MRI Systems (2012) 139
Table 86: France Market Segment, 2012 & 2020 141
Table 87: Germany Market Segment, 2012 & 2020 143
Table 88: Italy Market Segment, 2012 & 2020 144
Table 89: Spain Market Segment, 2012 & 2020 145
Table 90: United Kingdom Market Segment, 2012 & 2020 146
Table 91: 5EU Market by Country, 2012 & 2020 147
Table 92: 5EU Market Value by Market Segment for MRI Systems (2011-2020), $m 149
Table 93: France Market Value Forecast by Market Segment (2011-2020), $m 150
Table 94: France Installed Base of MRI Systems (2011-2020) 151
Table 95: Germany Market Value Forecast by Market Segment (2011-2020), $m 152
Table 96: Germany Installed Base of MRI Systems (2011-2020) 153
Table 97: Italy Market Value Forecast by Market Segment (2011-2020), $m 154
Table 98: Italy Installed Base of MRI Systems (2011-2020) 155
Table 99: Spain Market Value Forecast by Market Segment (2011-2020), $m 156
Table 100: Spain Installed Base of MRI Systems (2011-2020) 157
Table 101: United Kingdom Market Value Forecast by Market Segment (2011-2020), $m 158
Table 102: United Kingdom Installed Base of MRI Systems (2011-2020) 159
Table 103: Primary Research Interviews Completed by Country 173
Table 104: Primary Research Interviews Completed by Designation 174
List Of Figures
Figure 1: France Average Selling Price by Market Segment 50
Figure 2: Germany Average Selling Price by Market Segment 51
Figure 3: Italy Average Selling Price by Market Segment 52
Figure 4: Spain Average Selling Price by Market Segment 53
Figure 5: United Kingdom Average Selling Price by Market Segment 54
Figure 6: Average Age for Magnetic Resonance Imaging Machines in 5EU in 2013 77
Figure 7: 5EU Market Share for MRI Systems (2012) 135
Figure 8: France Market Share for MRI Systems (2012) 136
Figure 9: Germany Market Share for MRI Systems (2012) 137
Figure 10: Italy Market Share for MRI Systems (2012) 138
Figure 11: Spain Market Share for MRI Systems (2012) 139
Figure 12: United Kingdom Market Share for MRI Systems (2012) 140
Figure 13: France Market Segment, 2012 & 2020 142
Figure 14: Germany Market Segment, 2012 & 2020 143
Figure 15: Italy Market Segment, 2012 & 2020 144
Figure 16: Spain Market Segment, 2012 & 2020 145
Figure 17: United Kingdom Market Segment, 2012 & 2020 146
Figure 18: 5EU Market by Country, 2012 & 2020 148
Figure 19: 5EU Market Value by Market Segment for MRI Systems (2011-2020), $m 149
Figure 20: France Market Value Forecast by Market Segment (2011-2020), $m 151
Figure 21: France Installed Base of MRI Systems (2011-2020) 152
Figure 22: Germany Market Value Forecast by Market Segment (2011-2020), $m 153
Figure 23: Germany Installed Base of MRI Systems (2011-2020) 154
Figure 24: Italy Market Value Forecast by Market Segment (2011-2020), $m 155
Figure 25: Italy Installed Base of MRI Systems (2011-2020) 156
Figure 26: Spain Market Value Forecast by Market Segment (2011-2020), $m 157
Figure 27: Spain Installed Base of MRI Systems (2011-2020) 158
Figure 28: United Kingdom Market Value Forecast by Market Segment (2011-2020), $m 159
Figure 29: United Kingdom Installed Base of MRI Systems (2011-2020) 160
Figure 30: Primary Research Interviews Completed by Country 173
Figure 31: Primary Research Interviews Completed by Designation 174
Browse Full Report @
http://www.aarkstore.com/medical-devices/89616/medipoint-magnetic-resonance-imaging-systems-eu-analysis-and-market-forecasts
Contact Details:
Aarkstore Enterprise
Phone: +91 998 729 5242
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
No comments:
Post a Comment